Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021Sarah E Smith-Jeffcoat, Mary A Pomeroy, Sadia Sleweon, et al.
The Journal of Clinical Investigation|February 28, 2017
The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesisMaria A Stacey, Simon Clare, Mathew Clement, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Estimating the generation time for influenza transmission using household data in the United StatesLouis Yat Hin Chan, Sinead E Morris, Melissa S Stockwell, et al.
Epidemics|January 26, 2025
Estimating the generation time for influenza transmission using household data in the United StatesLouis Yat Hin Chan, Sinead E Morris, Melissa S Stockwell, et al.
The Journal of Infectious Diseases|July 3, 2021
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction TestingTalya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, et al.
Developmental Cell|November 23, 2024
Frizzled5 controls murine intestinal epithelial cell plasticity through organization of chromatin accessibilityLu Deng, Xi C He, Shiyuan Chen, et al.
NEJM Evidence|May 30, 2024
Intranasal Oxytocin for ObesityFranziska Plessow, Liya Kerem, Marie-Louis Wronski, et al.
Frontiers in Public Health|April 15, 2022
Risk-Factors for Exposure Associated With SARS-CoV-2 Detection After Recent Known or Potential COVID-19 Exposures Among Patients Seeking Medical Care at a Large Urban, Public Hospital in Fulton County, Georgia - A Cross-Sectional InvestigationSarah E Smith-Jeffcoat, Sadia Sleweon, Mitsuki Koh, et al.
ACS Medicinal Chemistry Letters|April 21, 2016
Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm InhibitorsHongfeng Deng, Jingye Zhou, Flora Sundersingh, et al.
JAMA Network Open|May 15, 2026
Recent COVID-19 Vaccination and Risk of SARS-CoV-2 TransmissionSara C Benist, Sarah E Smith-Jeffcoat, H Keipp Talbot, et al.
Pageof 12